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Owe&es. The aim of this study was to evaluate tbe predictors 
and clinical sequelae of stent thrombosis. 
Buckgrousd. Although coronary artery stenting is being tn- 
ereatingty applied, the major unique complication ufstent thmm- 
b&s is not well characterized. 
Merhads. We studied 145 patients who underwent coronary 
artery stenting with the Gianturcu.Ruubin flexible dl design for 
abrupt vessel closure or ta prevent resten&. There were 17 
sientsd vessel closures (ll.?%), 7 as a result of acute (<24 II) and 
10 of subacute (days I to 31) thrombosis. 
Rewlfs. In sewn patients sumss~ul cwonary Fecanaliution 
WBS achieved with thrmubol~tic agents and balloon anglaplasly. 
Crratiue kinase was significantly elevated in 13 patients, with a Q 
wake myacardial infarction in 11 and emergency coronary artery 
bypass gratting In 8. Comptisons (multivariate Wlysis) wiih a 
control cohort (n c 33) ot patients without thrombosis matched 
fur age, gender and veawt strnled revealed t&on eccen(ricity 
(p = 0.003), u&able angina (p = 0.048) and indication for stent 
implantation (abrupt closure venus restenusis) (p = OJW, BS 
predietars of tbrmnhutic ucclusiun of struted vessels. Subthen- 
peutie anttcoagulation (activated partint thromboplastin time -G 
times control value, prothrombio lime cl.4 control value) oc- 
curred at leasl once during the hospital stay iu all 10 patients with 
subacute thrumbusis and in 20 of 33 control patients (p = 0.047). 
In 2 patients with subacute thrombusis aud @I contrui subjects, 
suhtherapeutic an(icuagulation was necesritated by bls&lg. 
Conclusions. Early thrombosis after coronary scentlug *82 
relatively common (>tO%), uccurrlngpredamiuautty in eccentric 
lesions and in patients with uaskdde angina pedoris. Thii corn- 
plicaiiou is associated wilb slguiticant adverse etinical untcumes 
and may be reduced by tuore intensive antiioagulatien yet, in a 
d&ate balance, can be ptipkated by inadeqnate heprin 
therapy. 
(J Am Cdl Cardio11593;.21:622-7) 
Since the introduction of coronary angioplasty in 1977 (IL 
the problems of abrupt vessel closure and restenosis have 
become increasingly conspicuous and relatively intractable 
with balloon technology. The concept of endoluminal slenls 
was first introduced by Dotter and judkins (2,3), and these 
devices have been used to manage these problems with 
variable results. Some investigators (4.5) have reported a 
reduction in restenosis rates, but others (6) have noted no 
significant effect. Abrupt vessel closure has been S~CCCSS- 
fully treated with intracoronary stents (6-10). both as a 
bridge to emergency coronary artery bypass grafting and as 
a permanent intravascular prosthesis. However, acute and 
subacute thrombotic occlusion of stented vessels remains a 
significant problem in both settings (4-12). Certain factors, 
such as poor Row in the stented vessel, preexisting intralu- 
minal thrombus. small native vessel size, increased platelet 
counts. multiple overlapping stents, stentivessel diameter 
mismatch and the length of slent used have been suggested 
as factors predictive of thrombotic occlusion with the Pal- 
maz-Schatz stem prototype (It). Aggressive antithromhotic 
regimens are currently used routinely but periprocedural 
bleeding has been common. Whether these factors are also 
predictive ofrhrombotic occlusion forotherstent prototypes 
is unknown. 
The present study was designed. therefore, to examine 
the frequency and predictors of acute and subacute throm- 
botic occlusion of vessels with a flexible coil (Gianturco- 
Roubin) stent. and to examine the relations among anti- 
coagulation, stented vessel thrombosis and hemorrhagic 
periprocedural complications. 
From the +Diwslon oi Cardiology. University of Michigan Medical 
Cenkr. Ann Arbor. Michigan. tThe Riverside Melhodist Huspital. Colum- 
bus, Ohw and liThe Cleveland Clinic Foundation. Cleveland. Ohio. Methods 
Study patients. We retrospectively examined the hos- 
Mdress: Eric J. Toowl. MD. Rpartmenr olcardiol- 
O&Y. FZS. The Clsveland Clmw Foundation, YSW Euclid Avenue. Cleveland. 
Ohio 441PS. 
pital records of 145 consecutive patients who underwent 
Gianturco-Roubin slent implantation between February 1990 
and March 1991 at the University of Michigan Medical 
Center, Ann Arbor. Michigan and The Riverside Methodist 
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Hospital, Columbus, Ohio. Seventeen patieas w&h early 
thrombotic ncclusion (<4 ‘Keeks after stem ptacement) of 
the stented coronary arrery were identified. The clinical and 
angiographic characteristics of these patients were com- 
pared wiih those of 33 patients in the same cohort (n = 145). 
matched for age, gender and vessel stented. who did not 
experience thrombotic closure of the stunted vessel. The 
remainder of the cohort (95 patients) were not suitably 
matched for these three key variables. 
Indications for s!en! itn~!aotation. Cnrona~ dissection. 
Patients with coronary dissection associated with angio- 
graphic and hemodynamic evidence of abrupt vessel closure. 
imminent closure or threatened closure after repeated bal- 
loon inflation were considered candidates far intracoronarv 
stedt placement. Abrupt closure was defined as worsening 
stenosis with Thrombolysis in Myocardial Infarction (TIMI) 
grade 0 to 1 distal Row in a previously patent vessel with 
TIMI grade 3 flow and occurring during or after coronary 
angioplarty; threatened closure was defined as angiographic 
appearance during or tier angioplasty thought likely to be an 
increased risk for abrupt closure, despite preservation of nor- 
mal TIMI grade 3 Row in the distal vessel. Exclusion critetid 
were severe disc three-vessel coronary artery disease wirh- 
out functioning bypass grafts; vessel ~2.5 mm in diameter; 
distal segments beyond severe bends or branch points. pre- 
cluding stent placemeat: bleeding diatbesis or other disorder 
limiting the use of antiplatelet or anticoagulant therapy. 
Restenosis. Patients were considered eligible for stent 
implantation to prevent recurrent stenosis with subtotal or 
chronic tot& occlusions of native coronary arteries, with 
small or moderate vascular distributions if they had at least 
one restenosis after angioplasty of rhe vessel to be stented. 
Criteria for exclusion were the same as noted for patients 
with coronary dissection. 
Pmeedures. All patients were pretreated with oral, non- 
enteric coated aspirin, 325 mg daily, and dipyridamole. 
75 mg three times daily. beginning at least 24 h before the 
interventional procedure. For elective procedures, intrave- 
nous infusion of dextran 40 in dextrose at a rate of KM mVh 
was started 2 h before the procedure. After the first 500 ml 
was administered, the infusion rate was reduced to 40 ml/h 
and another 500 ml was administered. after which the 
infusion was discontinued. Patients in whom stent placement 
had not been anticipated were started on administration of 
intravenous dextran with the preceding regimen as soon as 
the decision to stent was made. All patienrs received intra- 
venous heparin during and after the procedure so as to keep 
the procedural activated clotting time >300 s and postpro- 
cedure activated panial throtnboplastin time between 60 and 
W s. Administration of ComTadin was started the night of 
the procedure and the dosz was adjusted to keep the 
prothrombin time between I7 and 20 s (>!.4 times control). 
After ptedilation with a standard angioplasty balloon cathe- 
ter, the stent was placed. 
Stem prepamrion. After the device was removed from 
the packaging, the distal lumen was flushed with heparinized 
saline sohnion. The balloon !gmen was prepared wirh stan- 
dard conrrasr-saline mixture. but without preintiting or 
purging the balloon hnnen. With a ZQ-ml syringe containing 
5 ml of contrascsaiine mixture. negative pressure was ap 
plied for 20 to 30 s. Pressure was then released, allowing 
negative pressure to draw the mixture into the balloon 
lumen: the syringe aas then detached,!eaving a meniscus of 
mixture on the hub of the b&Don lumen. The inflation device 
was prepared in the usual manner and after it was zuached to 
the ba!!oon !umen directly, negative pressure was applied. 
Care was taken to remove all air from the inRation device 
before attaching it, because significant amounts of air in the 
balloon might cause uneven expansion oi stent coils and 
di&ulty in deployment of the stent. With the large Tuohy 
Barst adapter wide open, the distal end of the stent balloon 
assembly was advanced over the guide wire and into the hub 
of the guiding ca~bnet, with cart taken not to ha&e the 
stent; if resistance was encountered, the device was wirh- 
drawn and examined for evidence of rtent damage. Fiily, 
the Tuohy-Bent Y adapter was luer-locked to the hub of the 
guiding catheter. 
Deployrenr of he stem After satisfactory guide cathe- 
ter stability was ensured, the stent was advanced until the 
proximal marker of the balloon (which is I to 2 mm proximal 
to the proximal end of the stent) was positioned a few 
millimeters proximal to the beginning of the arterial segment 
to be rtented. If the stent balloon catheter did not advance 
readily. force was not used. so as to avoid accordioning of 
the stent coils. In the event that guide catheter position was 
!ost, the stent was not withdrawn into the guide catheter. 
Instead, the guide catheter and stem were withdrawn IO- 
gether as one unit through the femoral sheath to prevent 
dislodgmcnt and embolism in the proximal aorta. Once 
adequate stent positioning was confirmed. the balloon was 
inflated to 4 to 5 atm, and subsequently to 6 to 8 atm, for a 
total of 30 to 60 s to firmly embed the stenl coils into the 
vessel intima. After balloon deilation and application of 
negative pressure, the balloon was slowly advanced =t mm 
to disengage the stent coils and was then withdrawn into the 
guide catheter. In the majority of patients. a single stent was 
placed. If multiple stents were required, overlapping of stent 
edges was avoided. 
Pafienl monagemenr after sfettring. Patients were mon- 
itored in the coronary care unit. Heparin levels were allowed 
to fali and femoral sheaths were removed when the activated 
partial lhromboplastin time decreased to c.55 s. A beparin 
infusion was subsequently restafied and activated partial 
thromboplastin time levels were kept more than two times 
the control level. Dextran administration was continued 
during the period of sheath removal and until the activated 
partial thromboplastin time was again therapeutic. Admlnis- 
tration ofcoumadin was started on the night of the procedure 
and the dose was adjusted to keep the prothrombin time at 
>1.4 times the control level. 
Review of roronory an&grams. All arI&iogramS were 
analyzed and each major epicardial coronary artery was 
evaluated in at least two rthogonal angiographic projections 
jointly by two experienced angiographers who had no knowl- 
edge of clinical details. All measurements were made by 
using selected tine frames at end&stole. 
Definitions. The following aogiographic definitions for 
thrombus and eccentricity, based on those used in the 
National Heart, Lung, and Blood Institute Bypass Angio- 
plasty Revascularization Investigation (BARI) (13). were 
recorded for each lesion. 
Thrombrrs. Thrombus was considered present if a dis- 
crete intraluminal filling defect of convex curvature within or 
adjacent to the stenotic region, largely separated fmm the 
adjacent vessel wall, was clearly definable in at least one view. 
Eccenfriciry. A stenosis was defined as eccentric when 
the location of the stenosis lumen lay in the outer quarter 
diameter of the apparent normal lumen. 
Dissection. A dissection was defined as a filling defect 
within the vessel wall (14). The geometry of the rent may be 
linear or coaxial, may wrap around the circumference of the 
vessel in a spiral geometric pattern or may be perpendicular 
to the long axis of the vessel. 
Anticoagulation data. The hospital records of all patients 
were reviewed. The activated partial thromboplastin time was 
considered therapeutic if it was >2 times the control level; a 
prothrombin time >I .4 times the control value was considered 
therapeutic. Anticoagulation adequacy was not assessed 
until 6 h after femoral artery and vein sheath removal. 
Candidate predktive indexes of stent closure. The follow- 
ing clinical and angiographic indexes were evaluated as 
possible predictors of stent closure: I) clinical: age, gender, 
subtherapeutic anticoagulation, indication for stenting, un- 
stable angina pectoris, hematoerit. platelet count: 2) an&- 
graphic: vessel stented, stent size, eccentricity, thrombus, 
dissection, lesion length, stenosis severity before and after 
stent placement. 
Acute or subcute vessel closure. Patients who experi- 
enced acute or subacute vessel closure were returned to the 
cardiac catheterization laboratory. in the event of throm- 
botic occlusion, intracoronary thrombolytic therapy was 
administered and repeat balloon dilation was performed in 
all patients. If these measures were unsuccessful, a decision 
regarding emergency bypass surgery was made, Blood was 
drawn for serum creatine kinase (CK) and CK-myocardial 
band isoenryme (MB) measurements on all patients every 
8 h after stenting for a total of three measurements. 
Other complications. Major bleeding was detined as that 
requiring transfusion of 22 red blood cell units or the occur- 
rence of intracranial hemorrhage. Transfusion decisions were 
made at the discretion of the attending physician on the basis of 
a significant hematocrit decrease (>lO%) from baseline and 
a low absolute value (~30%). Vascular complications were 
defined as the need for femoral vascular surgical repair. 
Statistics. A chi-square analysis ivas performed for cate- 
goric variables. An unpaired I test was used for continuous 
variables. A two-tailed p value < 0.05 was considered 
significant. Multiple logistic regression analysis was used to 
Table 1. Baseline Characteristics of 17 Patients With and 33 
Patients Wilhoul Thmmbosis After Coronary Artery Stemins 
Wilti Thrombasis Wlfhoul Thrombosrs 
I” = 17, ,” = 33, 
Age (yr) (mean f SDI 59+ IO 58? II 
Menlwomcn (no.) I 116 X,9 
Preview angioplasty 35 50 
Indica!ion far stenting 
Abrupt vessel closure 16 70 
Restenoris 24 30 
“nrtable angine 76’ 36’ 
Artery stented 
Lelt anterior descending 3s 33 
Left circumflex I8 25 
Right coronary 35 33 
Saphenous vein gran I2 9 
‘There were no rigsificant difference between Ihe grwps in any bas&e 
characteristic excwt unrlable angina (p < 0.051. Unless otherwise indicakd. 
data are preanled as percent of palienl group. 
assess the independent significance of several variables as 
predictors of early stent thrombosis. The variables assessed 
were age, gender, vessel stented, stent size, number of 
stents, clinical diagnosis (angina, unstable angina, recent 
myocardial infarction). anticoagulation status. angiographic 
morphology (lesion eccentricity, thrombns, dissection) and 
indication for stenting (abrupt vessel closure, suboptimal 
result, resterosis). Multivariate analysis by multiple logistic 
regression was performed to identify variables indepen- 
dently correlated with outcome of thrombosis by using only 
those variables significant at the p < 0.10 level in the 
univariate analysis. Analyses were performed using 
SYSTAT (the System for Statistics). 
Results 
Baseline patleut demqfrapttks end procedural factors. 
Table I shows the demographics of patients with and without 
thrombotic occlusion after coronary steding. There were no 
differences in baseline features between the patients with 
acute or subacute thrombosis, but the number of patients in 
each category was small. In Table 2. the data for stent 
placement are summarized. All stents were 20 mm long. 
Incidence of and time of stentcd vessel closure. Overall, 
there were I7 early thrombotic closures of stented vessels 
(11.7%); acute closure (<24 h) occurred in 7 patients, on 
average 1.1 -L 2.3 h after stent placement (range 0 to 6 h). and 
subacute closure occurred in IO patients a mean of 6.8 z 6.2 
days (range 2 to 23, Fii. 1) after stent placement, 
Lesion morphology. In patients who experienced throm- 
hotic occlusion of a vessel at the stent site, lesion eccentric- 
hy was significantly more common, occurring in 88% of 
patients with thrombosis compared with 21% of patients 
without thmmhosis (p < O.OMl). lnnaluminal rhrombus 
either before or after stent placement was also more corn- 
mon in the thrombosis group (65% vs. 18%. p < O.WI). 
Tabk 2. Stat Characteristics m the j0 Study Parients’ Table 3. Results of Coronary Stenting in the SO Study Pakm 
Stent size [mm1 
2.5 I? 0 
3.0 47 JO 
>3.0 $3 70 
Stenlr tno., 
Sin& 94 94 
Multiale 6 6 
*There were no slgn~ficam differences belwern Ihe goups tp < 0 OS. 
Unless otherwise indicated, data are preened as percenr of palien! group. 
Mean percent stenosis before stent placement (Table 3) was 
significantly greater in the group with than ‘n the group 
without stem thrombosis (77 2 17% vs. 58 ? 26%, p = 0.01). 
but there was no significant difference between the groups in 
the percent stenosis after stent placement (27 + 32% vs. 
21 k 12%). Lesion length before stent placement did not 
differ significantly between the groups with and without 
thrombosis (9 2 4 mm vs. 6 SC 6 mm, p = NS). A dissection 
was present before stent placement in 82% of patients with 
stent thrombosis but in only 52% of patients witbout throm- 
bosis (p = 0.07). 
Independent predictors of throatbasis. Independent cor- 
relates of thrombosis determined by multiple logistic regres- 
sion analysis were lesion eccentricity (p = 0.003). indication 
for stent placement (abrupt closure vs. restenosis) (p = 
0.002) and unstable angina peccoris (p = 0.048) (Table 4). 
Hemnt&gic variabk. Table 5 shows the platelet and 
white cell counts and the hematocrit levels. for the patients 
with thrombosis compared with control subjects, as well as 
the frequency of subtherapeutic anticoagulation. There was 
no significant difference between the platelet and white cell 
counts and hematccrit levels between the thrombosis and 
control groups. However, subtherapeutic anticoagulation 
(activated partial thromboplastin time <Z times control value 
with prothmmbin time ~1.4 times contml value) occurred in 
Figure I. Timing of slent thrombosis. 
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!K% of patients with subacute ihromboric closure compared 
with 61% of patients without thrombosis (p = 0.008). 
Cliaicsl outcomes (Tahk 4). Srenr reconolizorion. of 17 
stented vessels with acute or subacute closure, 7 (4%) were 
successfully reopened in the cardiac catheterization labora- 
tory. In ail patients intracoronary urokinase (mean dose 1.4 
million ? 0.8 million U) and balloon angioplasty were used. 
Of the IO patients in whom attempted recanakazation in the 
cardiac catheterization laboratory was unsuccessful, 8 147% 
of thrombosis patients) underwznt emergency coroaary by- 
pass grafting. 
Myacnrdinl infarcrion. Of the 17 patients with thrombo- 
sis. 14 (82%) sustained a rise in CK levels, and 12 (70%) 
developed a Q wave myocardial infarction. The mean peak 
CK level was 2.181) e 1,638 IU. 
Vnsc~rLr morbidity (Table 7). Vascular repair was re- 
quired in 5% (1 of 17) of patients with thmmbosis and 6% 
(2 of 33) of pxients without thmmbosis. Groin infection 
occurred in 0% of patients with thrombosis and 6% of those 
without thrombosis. Femoral neuropathy. resulting from 
compression by a large hematoma, occurred in I patient. 
Bhdimg. Major bleeding requiring transfusion occurred 
in 65% (I 1 of 17) of patients with thrombosis (mean transfu- 
sion requirements 4 z 3 red blood cell units) and 24% (8 of 
33) of patients without thrombosis (mean 10 f 9 U. p = 
0.005). In two patients with subacute thrombosis and II 
patients without thrombosis, bleeding was the reason for 
subtherapeutic anticoagulation, which may have contributed 
Table 4. Independenl Correlates of Stent Timnbu~!a iut&iplc Table 6. Treatment and Outcome nl Stent Thrombosis in 17 
logistic regression analysis) Patients 
Estimate Odds Ratio p value 
3.376 29.239 0.003 
-4.681 0.w o.w2 
LJnrlable angina 2.403 II ,051 0.048 
to thrombotic occlusion of the stented vessel in the former 
group. One patient, who received a total dose of 144 mg of 
intravenous tissue-type plasminogen activator. sustained 
intracranial bleeding. 
Therapy 
Caronary angioplasty 
Umkinare (mean dose 1.4 t 0.8 
million U) 
Successful recaanalization 
Outcome 
CK rise 
CK peak (IlJlmll 
Q have MI 
Emergency CABG 
DQth 
17 
17 
7 
14 
12 
8 
ml 
loo 
41 
a2 
L.ISO t 1.638 
70 
47 
0 
Learning CUM. As experience with managing patients 
with vessel stenting increased, the number of tbrombotic 
vessel closures decreased. When the study period was 
divided into thirds, the rate of thrombotic events decreased 
from 47% during the first third. to 35% in the second third 
and 18% during the final third of the study period. 
CABG = coronary artery bypass 8rafling; CK = creatine kin%; MI = 
myocardial inlarction. Data arc prerenred I number and prcenl of patient 
Sroup 0r mean value L SD. 
Discussion 
Our findings in a matched pair analysis demonstrate that 
stent thrombosis is most apt to occur in the setting of 
unstable anginawith eccentric lesions or abrupt closure, can 
be precipitated by inadequate anticoagulation and, despite 
therapy, is associated with serious adverse clinical out- 
comes. This coronary stent was the first to be recommended 
for commercial approval by the Food and Drug Administra- 
tion Advisory Panel (151, thus making it IikeIy that the 
absolute incidence of stent thrombosis will increase substan- 
tially. The present study helps to further characterize such 
events to facilitate optimal patient selection and postproce- 
dnral management in the future. 
Need for auticoagutation: 8 d&ate balance. Studies in 
animals (16) and in humans (I 1,12,17) have demonstrated the 
usefulness of antiplatelet and anticoagulant therapy in limit- 
ing the tendency to thromhotic stem occlusion. Indium-lll- 
labeled platelet scans in animals treated with aspirin, dipyr- 
idamole, heparin and dextran showed consistently less; 
thromhus in the stented vessels of these animals than in the 
stented vessels of control animals or animals given various 
combinations of heparin, aspirin and dipyridamole. Schatz 
and coworkers (12) noted a signilicantly lower incidence of 
thrombotic stented vessel occlusion in patients treated with 
anticoagulant and antiplatelet agents than in patients treated 
with only aspirin and dipyridamole. Similarly, in the multi- 
center follow-up of patients after placement of the self- 
expanding coronary artery stent (6). there was a significantly 
higher incidence of thrombotic stented vessel occlusion in 
patients treated with long-term subcutaneous heparin than in 
those receiving aspirin and Coumadin. Accordingly, auti- 
platelet and anticoagulant regimens clearly play a pivotal 
role in regulating thrombus formation after stent implanta- 
tion, and regimens used tuday often incorporate aspirin, 
dipyridamole. heparin and dextran in the p&procedural 
period, along with Coumadin for 3 to 6 months after stent 
implantation. However, this intensive polypharmaceutical 
antithrombotic regimen carries an important risk of bleeding 
and may not be fully prophylactic against stent thrombotic 
events. 
Incidem of early thmmlmsk. Our data indicate that 
early thrombotic occlusion occurs relatively commonly 
(11.7% of all stents placed) in vessels with the Giantureo- 
Roubin stent prototype; however, there is clearly a learning 
curve, with the number of early closures decreasing from 8 
(47%) during the first third of the study period 1o 3 (18%) 
during the last third. The learning curve may be related 10 
improvemenr in selection of patients, stent deployment or 
Table 5. Hemstologic Variables in the 50 Study Patients 
rlematocrit (%) 
Mekr count (;nm3) 
White bloti cell cant (mm’) 
Subtherwutic anticoagulation’ 
(for subacute closures. R = 10) 
Wlicn~r Without 
Thmmboris 
(n = 33) 
34 = 5 
22oMm t 70,ccHl 
9.342 t 4.153 
61% 
“L 
NS 
NS 
a.wB 
*Actiwed pPnial thmmbqlastin time C2 times baseline value and piothfomhin time < 1.4 timesbaselioc value. 
Table 1. Morbidity in Patients With and Without Stat 
Thmmboris 
~-- 
Patlrnlr With Pdtlcntc Wllholll 
Thiomkw Thromburir 
,n = 17, In - 331 D V’alue 
anticoagulation extent and surveillance. Thib point requires 
confirmation and further explanation in larger. mullicenrer 
experiences. As shown in Figure I. the events lend [acluster 
early but a liabilhy for stem thrombosis extends through the 
1st 3 weeks after successful deployment. 
Angiographic and clinical predictors of stent thmmbmis. 
Numerous lesion-related factors have heen identilied that 
predispose IO thrombotic occlusion of vessels wilh the 
Palmaz-Schatz stent or the Wallstent. These include re- 
verely curved segments (6,10.12,17): undr&ing of the final 
stent diameter, although a srentivessel diameter <I.? ap- 
pears to favor improved vessel patency: intraluminal filling 
defects before or after stent implantaGon: high phuelct 
count; the presence of unstable ischemic syndromes, such as 
unstable angina and acute myocardial infarction: the pres- 
ence of poor distal runoff (collateral vessels) and small 
vessels (~3 mm). Inaddition, the use of multiple overlapping 
stems is associated with a greater likelihood OF thmmbotic 
occlusion ofstented vessels. Some investigaators have noted 
an inverse correlation between stent length and occlusion 
rates. 
Univariate analysis of our data identified the presence of 
intraluminal thrombus and lesion eccentricity as predictors 
of thrombotic stent occlusion; multiple logistic regression 
analysis identified lesion eccentricity. unstable angina pec- 
totis and indication for stent placement (abrupt closure at 
higher risk than restenosis) as independent correlates of 
early Stent thrombosis. Tbc relatively limited use of small or 
multiple stents in the present study does not allow for 
evaluation of stent size or the role of multiple stents as 
possible contributors to stent thrombosis. 
In each of our patients who experienced subacute Ihrom- 
bayis, there was subtherapeutic anticoagulation on at least 
one occasion: in 18% of these patients, lowering ofthe level 
of anticoagulation was indicated clinically by major blced- 
ing. Previous workers have also noled the importance of 
adeouate anticoaEulation to ensure oatencv of stenled vcs- . 
scls (12). Our study was limited by the lack of using 
International Normalization Ratios to monitor the effective- 
ness of anticoagulation, a method especially useful when 
data from multiple centers are pooled. FurthernIorc. the 
optimal duration of anticoagulation remains io be defined. 
Stems implanted in porcine femoral arteries were completely 
endothelialized within 3 weeks, but the finding of ~tenl 
thrombosis in humans after 3 months despite anticoagulation 
(17) and rai\cs the o.ue4on5 of incomplete endothelializa- 
lion. 
The major limitation of coronary srenting is the risk of 
slenx throqbosls. which mandates inrensive anticoagulation 
and ils attcndanl bleeding complications. Our study points 
on! several cautionary flags with this particular stem. which 
will be imminently available throughour interventional cen- 
ters in the United States. Although not to be viewed as a 
cantrdindication. the setting of unsmble angina. especially 
with highly eccentric angiographic lesions, has unfavorable 
rssulrs rvith sreniing. Strict anticoagulation survciltsnce is 
required IU avert blent thrombosis but we clrarly need a 
regimen that has less b?eedinp hazard. achieves therapeutic 
Ievel~ more rapidly than Coumadin and is My ihrombopro- 
phylactic. 
